Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Keywords

@article{a90a96518cdd4f959725e8e0228aa30f,

title = "Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations",

keywords = "COLITIS",

author = "H.E.F. Becker and J. Penders and D.M.A.E. Jonkers",

note = "Funding Information: Heike Becker was funded by the NUTRIM Graduate Program Grant from Maastricht University.",

year = "2022",

month = jan,

day = "1",

doi = "10.1053/j.gastro.2021.07.050",

language = "English",

volume = "162",

pages = "4--8",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "Elsevier Saunders",

number = "1",

}

TY - JOUR

T1 - Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations

AU - Becker, H.E.F.

AU - Penders, J.

AU - Jonkers, D.M.A.E.

N1 - Funding Information: Heike Becker was funded by the NUTRIM Graduate Program Grant from Maastricht University.

PY - 2022/1/1

Y1 - 2022/1/1

KW - COLITIS

U2 - 10.1053/j.gastro.2021.07.050

DO - 10.1053/j.gastro.2021.07.050

M3 - Editorial

C2 - 34508777

SN - 0016-5085

VL - 162

SP - 4

EP - 8

JO - Gastroenterology

JF - Gastroenterology

IS - 1

ER -